EFX.NYSEEquifax INC

Form 4: Equifax CTO Receives Significant Equity Grant

Sentiment:

Insider Transaction Report


Equifax's Chief Technology Officer, Jamil Farshchi, was granted 14,221 shares of common stock as part of the company's long-term incentive plan.

Summary

  • Jamil Farshchi, Executive Vice President and Chief Technology Officer of Equifax Inc. (EFX), acquired 14,221 shares of common stock.
  • The acquisition occurred on February 25, 2026, as an annual equity grant pursuant to the company's long-term incentive plan.
  • These restricted stock units (RSUs) will vest 100% on February 25, 2029.
  • The transaction price for the acquired shares was $0.0000, indicating a grant rather than a cash purchase.
  • Following this transaction, Farshchi beneficially owns a total of 54,090 shares of Equifax common stock.
  • The total beneficial ownership includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units and 400 shares purchased via the Equifax Inc. 2020 Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as an equity grant to a key executive signals confidence in the company's future and aligns management incentives with shareholder interests.

Positives

  • The grant of 14,221 shares to a key executive, Jamil Farshchi, aligns management's interests with those of shareholders.
  • The long vesting period (until February 25, 2029) encourages long-term commitment and performance from the Chief Technology Officer.
  • The inclusion of dividend equivalent units further enhances the executive's stake in the company's ongoing success.

Future Outlook

The restricted stock units granted to the Chief Technology Officer are scheduled to vest 100% on February 25, 2029, indicating a long-term retention and incentive strategy for key management.

Industry Context

StockSavvy.ai notes that annual equity grants are a standard component of executive compensation packages across various industries, particularly in technology and financial services. These grants are designed to align the interests of executives with long-term shareholder value creation by tying a significant portion of their compensation to the company's stock performance and future growth.

Comparison to Industry Standards

  • Equity grants with multi-year vesting schedules, such as the 100% vesting on February 25, 2029, for Equifax's CTO, are a common practice among large publicly traded companies like Visa, Mastercard, and Experian.
  • This structure is consistent with global benchmarks for executive retention and performance incentives, ensuring executives have a vested interest in the company's sustained success over several years.

Stakeholder Impact

  • Shareholders: Positive, as executive equity ownership aligns management's long-term interests with shareholder value creation.
  • Employees: Potentially positive, as it signals stability in key leadership and a commitment to long-term incentive programs.

Next Steps

  • Continued employment and performance of Jamil Farshchi to meet vesting conditions.
  • Vesting of 14,221 restricted stock units on February 25, 2029.

Key Dates

DateDescription
02/25/2026Date of acquisition of 14,221 shares of common stock as an annual equity grant.
02/27/2026Date the Form 4 was signed by the reporting person's attorney-in-fact.
02/25/2029Vesting date for 100% of the 14,221 restricted stock units.

Keywords

Equifax, EFX, insider transaction, Form 4, equity grant, restricted stock units, executive compensation, Jamil Farshchi, Chief Technology Officer, long-term incentive plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.